NCT00261287View on ClinicalTrials.gov

Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)

PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Hay FeverPerennial Allergic Rhinitis
Interventions
DRUG

Ciclesonide

Trial Locations (3)

61761

Altana Pharma/Nycomed, Normal

78229

Altana Pharma/Nycomed, San Antonio

90806

Altana Pharma/Nycomed, Long Beach

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY